We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Greiner Bio-One

Download Mobile App


Study Finds Immunity to Coronavirus May Last Only Six Months with Reinfection Possible

A study by the University of Amsterdam (Amsterdam, the Netherlands) has found that immunity to human coronaviruses may last for only six months with a possibility of reinfection. More...
30 May 2020
Image: MicroFlow I Ductless Workstation (Photo courtesy of HEMCO Corporation)

HEMCO Corporation’s MicroFlow I Ductless Workstation Ensures Safety Comes First

Amidst the current pandemic, laboratory biosafety related to the coronavirus has assumed significant importance for laboratories and stakeholders involved in COVID-19 laboratory work. More...
29 May 2020
Image: The Purair® BIO biological safety cabinet (Photo courtesy of Air Science)

Air Science’s Purair BIO Biological Safety Cabinet Provides Safe Laboratory Workspace

Biosafety in the laboratory is critical when work involves infectious diseases and toxins, as well as in cell and tissue culturing, where product contamination must be avoided, particularly amidst the current COVID-19 pandemic. More...
29 May 2020

Sheba Medical Center’s New COVID-19 Inspired Immersive Simulation Patient Room Uses AI, AR and Robotic Monitoring

A new COVID-19 inspired immersive simulation patient room of the future at Sheba Medical Center (Tel HaShomer, Israel) realistically simulates extreme medical situations by combining live actors as patients and doctors, as well as robotic clinical simulators. More...
29 May 2020
Image: Universally Effective Antibodies Found in COVID-19 Patients Raise Hopes of Coronavirus Vaccine (Photo courtesy of The Rockefeller University)

Universally Effective Antibodies Found in COVID-19 Patients Raise Hopes of Coronavirus Vaccine

An immunological study of people who had recovered from COVID-19 showed that although the amount of antibodies they generated varied widely, most individuals had generated at least some that were intrinsically capable of neutralizing the SARS-CoV-2 virus. More...
29 May 2020
Image: Swift Normalase Amplicon Panel (SNAP) SARS-CoV-2 kit (Photo courtesy of Swift Biosciences, Inc.)

Swift Biosciences Launches Normalase Amplicon Panel (SNAP) SARS-CoV-2 Kit

Swift Biosciences, Inc. (Ann Arbor, MI, USA), which focuses on commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has released its Swift Normalase Amplicon Panel (SNAP) SARS-CoV-2 kit. More...
29 May 2020

Roche and Gilead Collaborate to Test Actemra-Remdesivir Cocktail in Severe COVID-19 Cases

Roche (Basel, Switzerland) has initiated a phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalized patients with severe COVID-19 pneumonia. More...
29 May 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.